Ocular Therapeutix (OCUL) Gross Profit (2016 - 2025)
Historic Gross Profit for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to $293000.0.
- Ocular Therapeutix's Gross Profit fell 9530.6% to $293000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.0 million, marking a year-over-year decrease of 10890.57%. This contributed to the annual value of -$2.0 million for FY2025, which is 10890.53% down from last year.
- According to the latest figures from Q4 2025, Ocular Therapeutix's Gross Profit is $293000.0, which was down 9530.6% from $1.5 million recorded in Q3 2025.
- In the past 5 years, Ocular Therapeutix's Gross Profit registered a high of $6.4 million during Q2 2024, and its lowest value of -$3.4 million during Q1 2025.
- Over the past 5 years, Ocular Therapeutix's median Gross Profit value was $3.2 million (recorded in 2021), while the average stood at $2.9 million.
- As far as peak fluctuations go, Ocular Therapeutix's Gross Profit soared by 65430.11% in 2022, and later tumbled by 17514.7% in 2025.
- Over the past 5 years, Ocular Therapeutix's Gross Profit (Quarter) stood at $3.2 million in 2021, then increased by 11.7% to $3.5 million in 2022, then skyrocketed by 56.82% to $5.6 million in 2023, then increased by 12.35% to $6.2 million in 2024, then plummeted by 95.31% to $293000.0 in 2025.
- Its Gross Profit stands at $293000.0 for Q4 2025, versus $1.5 million for Q3 2025 and -$270000.0 for Q2 2025.